| Title: | Interferons limit autoantigen-specific CD8(+) T-cell expansion in the non-obese diabetic mouse |
| Authors: | Jhala, G Krishnamurthy, B Brodnicki, TC Ge, TT Akazawa, S Selck, C Trivedi, PM Pappas, EG Mackin, L Principe, N Bremaud, E De George, DJ Boon, L Smyth, I Chee, J Kay, TWH Thomas, HE |
| Issue Year: | 2022 |
| Publisher | CELL PRESS |
| Series | CELL REPORTS: |
| Abstract | Interferon gamma (IFN gamma) is a proinflammatory cytokine implicated in autoimmune diseases. However, deficiency or neutralization of IFN gamma is ineffective in reducing disease. We characterize islet antigen-specific T cells in non-obese diabetic (NOD) mice lacking all three IFN receptor genes. Diabetes is minimally affected, but at 125 days of age, antigen-specific CD8(+) T cells, quantified using major histocompatibility complex class I tetramers, are present in 10-fold greater numbers in Ifngr-mutant NOD mice. T cells from ifngr-mutant mice have increased proliferative responses to interleukin-2 (IL-2). They also have reduced phosphorylated STAT1 and its target gene, suppressor of cytokine signaling 1 (SOCS-1). IFN gamma controls the expansion of antigen-specific CD8(+) T cells by mechanisms which include increased SOCS-1 expression that regulates IL-2 signaling. The expanded CD8(+) T cells are likely to contribute to normal diabetes progression despite reduced inflammation in Ifngr-mutant mice. |
| URI: | https://publications.svi.edu.au/publications/8739 |
| Other Identifiers | 10.1016/j.celrep.2022.110747 |
| Publication type | Article |